Home › Trial NCT03548467
A Study to Evaluate Safety and Efficacy of Multiple Dosing With VB10.NEO and Bempegaldesleukin (NKTR-214) Immunotherapy in Patients With Locally Advanced or Metastatic Cancer
- Trial IDNCT03548467
- StatusCompleted
- PhasePhase 1/2
- Study typeInterventional
- SponsorNykode Therapeutics ASA
- Enrollment41
- Start date2018-04-04
- ConditionsLocally Advanced or Metastatic Solid Tumours
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.